-
Posted by
Two Blokes Apr 17 -
Filed in
Stock
-
5 views
Abbott Laboratories NYSE: ABT is not immune to the impact of tariffs on its medical device business. However, the company's diversified business is tariff-resistant, and moves are being made to strengthen it further.
